By upregulating its corresponding ligand (PD-L1), tumor cells are able to suppress the T cell’s killing effect, whereas the blockage of the PD1/PD-L1 pathway through ICIs allows for recovering the T cells effector function for destroying the cancer cells [1]. This evidence concerns the gene PDCD1 and cancer.